ACM
ANAB icon

ADAR1 Capital Management’s AnaptysBio ANAB Stock Holding History

ADAR1 Capital Management’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,500
Closed -$37.6K – 283
2024
Q2 		$37.6K Sell
1,500
-500
-25% -$11.6K 0.01% 201
2024
Q1 		$45K Buy
+2,000
New +$47.4K 0.01% 186

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

ADAR1 Capital Management's ANAB Position: Q1 2026 in Review

ADAR1 Capital Management opened a new position in AnaptysBio (ANAB) in Q1 2026: 3,698 shares worth $205K. The stake represents 0.01% of the portfolio and ranks #258 among its holdings. This is a return to the name: ADAR1 Capital Management previously reported a position in ANAB as recently as Q4 2024.

ADAR1 Capital Management first reported a position in ANAB in Q1 2024 and has held it in 5 quarters since. The position peaked at $6.46M in Q3 2024. 207 funds tracked by Wall St. Rank hold ANAB as of Q1 2026.

  • ADAR1 Capital Management held 3,698 shares of AnaptysBio worth $205K as of Q1 2026.
  • AnaptysBio was a new ADAR1 Capital Management position in Q1 2026.
  • AnaptysBio made up 0.01% of ADAR1 Capital Management's portfolio in Q1 2026, its #258 holding.
  • ADAR1 Capital Management first reported a position in AnaptysBio in Q1 2024 and has held it in 5 quarters since.
  • ADAR1 Capital Management's AnaptysBio position peaked at $6.46M in Q3 2024.
  • 207 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2026.

Based on ADAR1 Capital Management's 13F filing for Q1 2026, filed 18 May 2026.